vs
Side-by-side financial comparison of Cytosorbents Corp (CTSO) and Velo3D, Inc. (VELO). Click either name above to swap in a different company.
Velo3D, Inc. is the larger business by last-quarter revenue ($9.4M vs $9.2M, roughly 1.0× Cytosorbents Corp). Cytosorbents Corp runs the higher net margin — -59.5% vs -231.9%, a 172.4% gap on every dollar of revenue. On growth, Cytosorbents Corp posted the faster year-over-year revenue change (0.9% vs -25.2%). Cytosorbents Corp produced more free cash flow last quarter ($-4.9M vs $-8.3M). Over the past eight quarters, Cytosorbents Corp's revenue compounded faster (1.3% CAGR vs -1.8%).
CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.
Velo3D, Inc. develops and sells advanced end-to-end metal additive manufacturing (3D printing) solutions, comprising industrial-grade printers, specialized processing software, and high-performance metal materials. It primarily serves global aerospace, defense, energy, semiconductor and industrial manufacturing markets, enabling customers to produce complex, high-precision metal parts that are difficult to manufacture with traditional methods.
CTSO vs VELO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.2M | $9.4M |
| Net Profit | $-5.5M | $-21.9M |
| Gross Margin | 73.7% | -73.6% |
| Operating Margin | -47.5% | -231.0% |
| Net Margin | -59.5% | -231.9% |
| Revenue YoY | 0.9% | -25.2% |
| Net Profit YoY | 27.4% | -2.9% |
| EPS (diluted) | $-0.09 | $-0.87 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.2M | $9.4M | ||
| Q3 25 | $9.5M | $13.6M | ||
| Q2 25 | $9.6M | $13.6M | ||
| Q1 25 | $8.7M | $9.3M | ||
| Q4 24 | $9.2M | $12.6M | ||
| Q3 24 | $8.6M | $8.2M | ||
| Q2 24 | $8.8M | $10.3M | ||
| Q1 24 | $9.0M | $9.8M |
| Q4 25 | $-5.5M | $-21.9M | ||
| Q3 25 | $-3.2M | $-11.2M | ||
| Q2 25 | $1.9M | $-13.3M | ||
| Q1 25 | $-1.5M | $-25.0M | ||
| Q4 24 | $-7.6M | $-21.3M | ||
| Q3 24 | $-2.8M | $-21.9M | ||
| Q2 24 | $-4.3M | $935.0K | ||
| Q1 24 | $-6.1M | $-27.5M |
| Q4 25 | 73.7% | -73.6% | ||
| Q3 25 | 70.3% | 3.2% | ||
| Q2 25 | 70.9% | -11.7% | ||
| Q1 25 | 71.1% | 7.5% | ||
| Q4 24 | 68.4% | -3.5% | ||
| Q3 24 | 61.0% | 49.4% | ||
| Q2 24 | 73.5% | -28.0% | ||
| Q1 24 | 76.5% | -28.8% |
| Q4 25 | -47.5% | -231.0% | ||
| Q3 25 | -30.2% | -73.3% | ||
| Q2 25 | -37.6% | -85.4% | ||
| Q1 25 | -44.5% | -123.6% | ||
| Q4 24 | -37.1% | -167.0% | ||
| Q3 24 | -56.1% | -213.8% | ||
| Q2 24 | -40.4% | -187.7% | ||
| Q1 24 | -51.8% | -211.1% |
| Q4 25 | -59.5% | -231.9% | ||
| Q3 25 | -33.4% | -82.0% | ||
| Q2 25 | 20.2% | -97.7% | ||
| Q1 25 | -16.9% | -268.4% | ||
| Q4 24 | -82.7% | -168.5% | ||
| Q3 24 | -32.1% | -265.3% | ||
| Q2 24 | -48.6% | 9.0% | ||
| Q1 24 | -67.7% | -281.2% |
| Q4 25 | $-0.09 | $-0.87 | ||
| Q3 25 | $-0.05 | $-0.65 | ||
| Q2 25 | $0.03 | $-0.94 | ||
| Q1 25 | $-0.02 | $-1.87 | ||
| Q4 24 | $-0.14 | $7.06 | ||
| Q3 24 | $-0.05 | $-35.52 | ||
| Q2 24 | $-0.08 | $1.65 | ||
| Q1 24 | $-0.11 | $-55.51 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.2M | $39.0M |
| Total DebtLower is stronger | — | $31.0M |
| Stockholders' EquityBook value | $5.9M | $38.2M |
| Total Assets | $44.2M | $105.3M |
| Debt / EquityLower = less leverage | — | 0.81× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.2M | $39.0M | ||
| Q3 25 | $7.5M | $11.8M | ||
| Q2 25 | $10.2M | $854.0K | ||
| Q1 25 | $11.6M | $3.9M | ||
| Q4 24 | $3.3M | $1.2M | ||
| Q3 24 | $5.7M | $1.6M | ||
| Q2 24 | $8.5M | $3.2M | ||
| Q1 24 | $8.6M | $10.9M |
| Q4 25 | — | $31.0M | ||
| Q3 25 | — | $23.0M | ||
| Q2 25 | — | $22.5M | ||
| Q1 25 | — | $21.7M | ||
| Q4 24 | — | $5.7M | ||
| Q3 24 | $13.8M | $32.3M | ||
| Q2 24 | $13.7M | $33.5M | ||
| Q1 24 | $4.4M | $44.0M |
| Q4 25 | $5.9M | $38.2M | ||
| Q3 25 | $9.0M | $29.9M | ||
| Q2 25 | $11.6M | $21.4M | ||
| Q1 25 | $14.5M | $32.8M | ||
| Q4 24 | $11.1M | $39.7M | ||
| Q3 24 | $13.4M | $34.4M | ||
| Q2 24 | $17.4M | $52.1M | ||
| Q1 24 | $19.6M | $45.5M |
| Q4 25 | $44.2M | $105.3M | ||
| Q3 25 | $45.8M | $93.7M | ||
| Q2 25 | $48.0M | $78.4M | ||
| Q1 25 | $50.8M | $91.3M | ||
| Q4 24 | $47.4M | $89.2M | ||
| Q3 24 | $47.8M | $110.8M | ||
| Q2 24 | $53.4M | $116.7M | ||
| Q1 24 | $47.1M | $136.1M |
| Q4 25 | — | 0.81× | ||
| Q3 25 | — | 0.77× | ||
| Q2 25 | — | 1.05× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | 1.03× | 0.94× | ||
| Q2 24 | 0.78× | 0.64× | ||
| Q1 24 | 0.23× | 0.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-4.8M | $-7.7M |
| Free Cash FlowOCF − Capex | $-4.9M | $-8.3M |
| FCF MarginFCF / Revenue | -53.4% | -88.3% |
| Capex IntensityCapex / Revenue | 1.2% | 6.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-12.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-4.8M | $-7.7M | ||
| Q3 25 | $-2.6M | $-6.0M | ||
| Q2 25 | $-1.5M | $-1.2M | ||
| Q1 25 | $-3.5M | $-12.3M | ||
| Q4 24 | $-2.3M | $-2.2M | ||
| Q3 24 | $-2.5M | $-2.0M | ||
| Q2 24 | $-4.8M | $-8.0M | ||
| Q1 24 | $-4.8M | $-20.5M |
| Q4 25 | $-4.9M | $-8.3M | ||
| Q3 25 | $-2.6M | $-6.3M | ||
| Q2 25 | $-1.5M | $-3.0M | ||
| Q1 25 | $-3.5M | — | ||
| Q4 24 | $-2.4M | $-2.2M | ||
| Q3 24 | $-2.6M | $-2.0M | ||
| Q2 24 | $-4.8M | $-8.0M | ||
| Q1 24 | $-4.9M | $-20.5M |
| Q4 25 | -53.4% | -88.3% | ||
| Q3 25 | -27.3% | -46.5% | ||
| Q2 25 | -16.1% | -22.2% | ||
| Q1 25 | -39.7% | — | ||
| Q4 24 | -26.3% | -17.7% | ||
| Q3 24 | -30.4% | -24.2% | ||
| Q2 24 | -54.4% | -77.1% | ||
| Q1 24 | -54.2% | -209.8% |
| Q4 25 | 1.2% | 6.4% | ||
| Q3 25 | 0.2% | 2.3% | ||
| Q2 25 | 0.4% | 13.3% | ||
| Q1 25 | 0.0% | 0.0% | ||
| Q4 24 | 0.8% | 0.2% | ||
| Q3 24 | 1.8% | 0.2% | ||
| Q2 24 | 0.2% | 0.0% | ||
| Q1 24 | 0.5% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.78× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -8.52× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTSO
| Direct | $5.1M | 55% |
| Distributors And Strategic Partners | $4.2M | 45% |
VELO
Segment breakdown not available.
